Domicile
Reels
Groupes
Pages
Plus
Groupes Pages Blogs
Log In Register
Light Theme
Febrile Neutropenia Market Drivers, Challenges, and Forecast 2032
The Febrile Neutropenia Market is gaining strategic importance within the global oncology and infectious disease treatment landscape. Febrile neutropenia (FN) is a serious complication commonly associated with chemotherapy, characterized by fever and a significant reduction in neutrophil count, leaving patients highly vulnerable to infections. In 2024, the market was valued at US$ 10,789.45...
0 Commentaires ·0 Parts ·36 Vue ·0 Aperçu
Connectez-vous pour aimer, partager et commenter!